Studies have shown that, in lung cancer, Interleukin 6 (IL‐6) can not only promote the self‐renewal of CD133+ CSC‐like cells but also promote DNA repair and protect CD133+ CSC‐like cells from apoptosis and death.85 Here, IL6 is linked to lung carcinoma.